(19)

(11)

EP 4 093 469 A1

(12)

(43) Date of publication: 30.11.2022 Bulletin 2022/48 (21) Application number: 20916029.0 (22) Date of filing: 18.10.2020

(51) International Patent Classification (IPC):  A61M 25/00(2006.01) A61L 2/00(2006.01) A61N 5/06(2006.01) A61L 2/08(2006.01) (52) Cooperative Patent Classification (CPC): A61M 25/00; A61N 5/0624; A61M 2025/0019 (86) International application number: PCT/US2020/056219 (87) International publication number: WO 2021/150279 (29.07.2021 Gazette 2021/30)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 20.01.2020 US 202016747315 (71) Applicant: Light Line Medical, Inc. Salt Lake City, UT 84108 (US)

(72) Inventors: LONG, Curtis D. Salt Lake City, Utah 84104 (US) BARNECK, Mitchell D. Salt Lake City, Utah 84015 (US) RHODES, Nathaniel L. Salt Lake City, Utah 84115 (US) ALLEN, James P. Salt Lake City, Utah 84105 (US) DE LA PRESA, Martin Salt Lake City, Utah 84103 (US) (74) Representative: Pawlyn, Anthony Neil  Murgitroyd & Company Cardiff Churchill House Churchill Way Cardiff CF10 2HH Cardiff CF10 2HH (GB)